Treating ischaemia‐reperfusion injury with prostaglandin E1 reduces the risk of early hepatocellular carcinoma recurrence following liver transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|269-2813|9|1101-1110

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.269-2813, Iss.9, 2015-11, pp. : 1101-1110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treating ischaemia‐reperfusion injury with prostaglandin E1 reduces the risk of early hepatocellular carcinoma recurrence following liver transplantation

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 9, 2015-11 ,pp. : 1101-1110

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prostaglandin E1 improves hepatic encephalopathy produced by ischaemia-reperfusion liver injury in rats

By Adachi Naoto   Ochi Tomoko   Tabo Etsuo   Nagaro Takumi   Arai Tatsuru  

Intensive Care Medicine, Vol. 26, Iss. 11, 2000-11 ,pp. : 1681-1684

Springer Publishing Company

Access to resources Recommend Favorite

Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation

By  

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 10, 2015-09 ,pp. : 1250-1257

John Wiley & Sons Inc

Access to resources Recommend Favorite

Platelet Factor 4 Limits Th17 Differentiation and Ischaemia–Reperfusion Injury After Liver Transplantation in Mice

By  

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (ELECTRONIC), Vol. 81, Iss. 2, 2015-02 ,pp. : 129-134

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 24, Iss. 1, 2018-01 ,pp. : 44-55

John Wiley & Sons Inc

Access to resources Recommend Favorite